Landscape of Oligometastatic Disease in Esophageal Cancer – Richard van Hillegersberg
Oligometastatic disease is gaining attention for its treatment through local and systemic therapies. Recent trials, especially in squamous cell carcinoma, are discussed, highlighting the need for clearer criteria and a European cancer group to standardize definitions. The OMIC five trial compares systemic therapy durations and the role of surgery, promoting…














